GaluxDesign achieved the broadest target coverage among publicly comparable de novo antibody design studies, identifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results